A rare and potentially deadly viral illness, Lassa fever, is suspected in the death of an Iowa resident who recently returned from West Africa. The patient died earlier today after being hospitalized in isolation at the University of Iowa Health Care Medical Center. While preliminary testing at the Nebraska Laboratory Response Network indicated a presumptive positive result for Lassa fever, confirmatory testing is underway, according to the Centers for Disease Control and Prevention (CDC).
The case is particularly concerning due to the rarity of Lassa fever in the United States. The CDC assesses the risk to the general public as extremely low, noting the patient did not exhibit symptoms while traveling, minimizing the potential for transmission to fellow passengers. However, the incident underscores the ongoing global health risks associated with emerging infectious diseases and the importance of rapid diagnosis, and response.
Lassa fever, endemic to parts of West Africa, is a viral hemorrhagic fever transmitted to humans through contact with the urine or droppings of the multimammate rat, Mastomys natalensis. The virus can then spread between humans through direct contact with infected bodily fluids – blood, urine, saliva, and other secretions – or through mucous membranes. It is not spread through casual contact, and individuals are not considered infectious until they begin to show symptoms.
Understanding Lassa Fever: A West African Threat
The World Health Organization estimates that 100,000 to 300,000 cases of Lassa fever occur annually in West Africa, with approximately 5,000 deaths. The illness often presents with flu-like symptoms initially, making early diagnosis challenging. These can include fever, fatigue, muscle pain, and headache. However, in more severe cases, Lassa fever can lead to hemorrhagic manifestations – bleeding from gums, nose, or other orifices – as well as neurological complications, including hearing loss, which is a common long-term sequela even after recovery.
According to the CDC’s Lassa Fever page, approximately 80% of Lassa fever infections are mild or asymptomatic. However, the fatality rate among hospitalized patients can range from 15% to 20%. The virus attacks multiple organs, including the liver, kidneys, and central nervous system.
A Rare Occurrence in the United States
This suspected case in Iowa marks only the ninth known instance of Lassa fever in a traveler returning to the United States since 1969. The CDC is actively collaborating with the Iowa Department of Health to investigate the circumstances surrounding the patient’s infection, focusing on potential exposure to rodents during their time in West Africa. Federal assistance has been offered to Iowa to support the investigation and contact tracing efforts.
Health officials are currently identifying individuals who may have had close contact with the patient after the onset of symptoms. These contacts will be monitored for a period of 21 days, the maximum incubation period for Lassa fever, to detect any signs of illness. The CDC emphasizes that transmission is only possible when an infected person is exhibiting symptoms.
What is Being Done to Prevent Further Spread?
The CDC is providing support to Iowa public health officials, including expertise in Lassa fever diagnosis, treatment, and infection control. The agency is also working to ensure that healthcare facilities in the area are prepared to recognize and manage potential cases.
“Early information suggests the patient may have had contact with rodents while in West Africa,” a CDC statement released today confirmed. This highlights the importance of preventative measures for travelers to endemic areas, including avoiding contact with rodents and their droppings, practicing good hygiene, and being aware of the symptoms of Lassa fever.
Looking Ahead: Confirmatory Testing and Continued Monitoring
The immediate priority is to obtain confirmatory testing results from the CDC to definitively confirm the diagnosis of Lassa fever. In the meantime, public health officials will continue to monitor close contacts of the deceased patient and provide guidance on preventative measures. The CDC will provide updates as more information becomes available.
The CDC continues to emphasize that the risk to the general public remains extremely low. However, this case serves as a reminder of the importance of global health surveillance and preparedness in the face of emerging infectious diseases. Travelers to West Africa are advised to consult the CDC’s Travelers’ Health website for the latest recommendations and precautions.
This story will be updated as more information becomes available.
If you have concerns about potential exposure or are experiencing symptoms consistent with Lassa fever, please contact your healthcare provider immediately.
Do you have thoughts on this story? Share them in the comments below.
